LoginSignup
Medpace Holdings logo

Medpace Holdings

Stock
Stock
Ticker: MEDP
MEDP

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Medpace Holdings is $17.09B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Medpace Holdings is 35.92. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Medpace Holdings's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $17.05. EPS indicates the company's profitability on a per-share basis.
Currently, 15 analysts cover Medpace Holdings's stock, with a consensus target price of $601.09. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Medpace Holdings reported a revenue of $2.78B.
Medpace Holdings's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $611.20M. EBITDA measures the company's overall financial performance.
Medpace Holdings has a free cash flow of $706.69M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Medpace Holdings employs approximately 6,200 people. It operates in the Health Care sector, specifically within the Miscellaneous Commercial Services industry.
The free float of Medpace Holdings is 22.47M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$17.09B
EPS (TTM) 
$17.05
Free Float 
22.47M
P/E ratio (TTM) 
35.92
Revenue (TTM) 
$2.78B
EBITDA (TTM) 
$611.20M
Free Cashflow (TTM) 
$706.69M

Pricing

1D span
$614.53$616.02
52W span
$373.00$677.90

Analyst Ratings

The price target is $601.09 and the stock is covered by 15 analysts.

Buy

2

Hold

11

Sell

2

Information

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

Employees
6,200
Industries
Miscellaneous Commercial Services
Sector
Health Care

Identifier

Primary Ticker
MEDP

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin